Low serum interleukin-1 receptor antagonist level leads to poor outcomes in hepatitis B-related liver failure patients
-
摘要: 目的 白细胞介素-1受体拮抗剂(IL-1ra)是炎症细胞因子IL-1的天然拮抗剂,在许多炎症性疾病中发挥关键作用。本研究探讨IL-1ra在乙型肝炎相关肝衰竭(HB-ACLF)中的作用。 方法 采集31例HB-ACLF、28例急性乙型肝炎(AHB)、31例慢性乙型肝炎(CHB)患者及15例健康对照者(healthy controls,HC)外周静脉血,用Q-Plex法检测外周血IL-1ra、IL-1β、IL-6、IL-4、IL-10、TNF-α及IFN-γ浓度,并分析肝衰竭患者存活组与死亡组各细胞因子的差异。 结果 HB-ACLF患者血清IL-1ra平均浓度为(338.9±268.8)pg/ml,与AHB[(182.7±123.1)pg/ml,P=0.012]、CHB[(77.07±40.5)pg/ml,P<0.001]及HC[(37.9±15.6)pg/ml,P<0.001]比较,浓度最高。但HB-ACLF患者IL-1ra/IL-1β比例(2.96±1.54)较AHB患者(4.54±2.29)低(P=0.048)。AHB患者血清IL-1ra浓度亦较CHB患者(P<0.001)及HC(P<0.001)高。在HB-ACLF患者中,最终死亡患者外周血IL-1ra浓度(P=0.02)及IL-1ra/IL-1β比值(P=0.007)均比存活者低。 结论 IL-1ra在HB-ACLF发展过程中起重要作用,与HB-ACLF患者预后相关。
-
关键词:
- 白介素-1受体拮抗剂 /
- 慢加亚急性肝衰竭 /
- 乙型肝炎 /
- 慢性
Abstract: Objective To investigate the correlation of serum interleukin-1 receptor antagonist(IL-1RA) levels to outcomes of hepatitis B-related liver failure. Methods For the 31 hepatitis B-related acute-on-chronic liver failure patients,28 acute hepatitis B patients,30 chronic hepatitis B patients and 15 health controls,the serum IL-1ra and other six cytokines were measured by using Q-Plex.We further analyzed the concentrations of cytokines between death and survival HB-ACLF patients. Results The serum IL-1ra concentration was highest in patients with HB-ACLF[(338.9±268.8)pg/ml] when compared to those in AHB[(182.7±123.1)pg/ml,P=0.012],CHB[(77.07±40.5)pg/ml,P<0.001] and HCs [(37.9±15.6)pg/ml,P<0.001].However,the ratio of IL-1ra to IL-1β in patients with HB-ACLF(2.96±1.54) was lower than that in AHB patients(4.54±2.29),P=0.048.Serum IL-1ra in AHB patients was also higher than those in CHB(P<0.001) and HCs(P<0.001).Both IL-1ra(P=0.02) and IL-1ra/IL-1β(P=0.007) were lower in No-survivors than Survivors in HB-ACLF patients. Conclusion IL-1ra plays an important role in the development of HB-ACLF and is associated with outcome of HB-ACLF.
点击查看大图
计量
- 文章访问数: 151
- HTML全文浏览量: 29
- PDF下载量: 0
- 被引次数: 0